A clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, with research and development operations ...

TECregen, a Swiss biotech advancing thymus regeneration, has announced the successful completion of a 10 million Swiss francs ...

European private equity company Andera Partners today announced that it is co-leading a $159.8 million Series A round of ...

UK-based clinical-stage ophthalmic gene therapy biotech Beacon Therapeutics today announced that it has raised over $75 ...

UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...

Swiss biotech TECregen has raised 10 million Swiss francs ($12.6 million) in seed financing to advance its thymus ...

Swiss specialty drugmaker Santhera Pharmaceuticals announces it has signed an exclusive licensing agreement with Nxera Pharma ...

US biotech InduPro Therapeutics has announced a global strategic collaboration and licensing agreement, and equity investment ...

The launch of USA-based Poplar Therapeutics has been announced, alongside a $50 million Series A financing led by SR One, ...

Following rumors over the last couple of days, US pharma major Eli Lilly has confirmed that it plans to acquire Ventyx ...

Singapore headquartered biotech Nuevocor today announced the appointment of Al Gianchetti as chief executive (CEO) and member of the board of directors.

Indian drugmaker Granules India (BSE: 532482) has announced its US subsidiary has secured tentative approval from the ...